PepsiCo CEO Ramon Laguarta brushed off growing worries about the potential effects of GLP-1 drugs on the food industry during discussions on October 10th.This coincides with the company revising its annual earnings projection upwards, even amidst...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Accept CookiesPrivacy policy
